8 The general blood pressure target for people with diabetes has now been revised to 130/80 mmHg by the American Diabetes Association, and the systolic blood pressure target recommended by KDIGO for patients with CKD not on dialysis is less than 120 mmHg
Moreover, the modified GLP-1 RAs, which are designed to activate the GLP-1 receptor more effectively, have stronger neuroprotective efficacy than GLP-1 RAs used in clinical practice
A recent publication has detailed the user profile of semaglutide 2.4-mg in real-world settings during this timeframe, which helps identify if this group is at risk for osteoporosis [21]
Irfan Khan provides personalized insights into these medications, helping patients choose the right GLP-1 option for their weight loss journey
The triple-agonist mechanism doesn't seem to cause different types of side effects than tirzepatide or semaglutide
For injection fundamentals, see the peptide injections complete guide